Navigation Links
Shimadzu and EDDA Announce Business Partnership on X-ray Chest CAD Applications
Date:11/11/2009

statistics such as those from WHO, ratio of death from cancer in the recent years tends to be decreasing. However, that from lung cancer is remarkably increasing, " said Mr. Kunimasa Itoh, general manager, marketing dept., medical systems division of Shimadzu Corporation. "Through the partnership with EDDA, who is expert of application development in this field, we will be able to contribute to improving clinical workflow and quality care of patients by providing advanced image diagnosis solutions to aid in early detection of lung lesions."

"Our partnership with Shimadzu Corporation reflects the increasingly important role that advanced computer application plays in enhancing clinical workflow to be faster, better and more cost-effective," said Dr. Jian-Zhong Qian, president and CEO of EDDA Technology. "We are pleased to partner with Shimadzu to offer new solutions to the diagnosis and management of potentially life-threatening lung diseases."

(* Regulatory approval for the distribution through Shimadzu in Japan and other countries are pending as of this moment.)

About Shimadzu Corporation

Founded in 1875, Shimadzu Corporation, a leader in the development of advanced technologies, has a distinguished history of innovation build on the foundation of contributing to society through science and technology. Shimadzu maintain a global network of sales, service, technical support and applications centers on six continents, and have established long-term relationship with a host of highly trained distributors located in over 100 countries.

About EDDA Technology

EDDA Technology, Inc. is an innovative clinical computer solution provider in diagnostic imaging and analysis. EDDA offers a series of new generation software products to enable early detection of diseases, and enhance efficiency and precision in diagnosis and treatment. EDDA's goal is to deliver, with broad accessibility, advanced information a
'/>"/>

SOURCE Edda Technology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... bloggers and influencers across North America ... that melanoma prevention begins with parents-encouraging everyone to create a ... Duff , and parenting author Alyson Schafer are ... Monday to share this poignant video message: Click ... Cornfield Melanoma Fund (DCMF)-producers of the viral video ...
(Date:5/6/2015)... , May 06, 2015 Research and ... the addition of the "Cannulas Market by ... Injector, Infusion, Venous, Microcannula), Material (Plastic, Metal) & ... Forecast to 2020" report to their offering. ... to grow at a CAGR of 5.6% from ...
(Date:5/6/2015)... Maine , May 6, 2015  Membership in ... according to a Healthcare Business Strategy report released ... also known as Medigap or Med Supp plans, ... 31, 2014, a 5.2% increase from 2013. Between ... increased by 551,135 covered lives.  Though UnitedHealth was ...
Breaking Medicine Technology:Celebrities Tweet Their Support of Melanoma Awareness Month and #newfamilyrule 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 3Continued Growth in Med Supp Market for 2014 according to Mark Farrah Associates 2
... Ardea Biosciences, Inc.,(Nasdaq: RDEA ) announced ... Highly Selective MEK1/2 Inhibitor is Beneficial in Dextran ... was presented at the,American College of Gastroenterology (ACG) ... provided data from a preclinical study of,RDEA119, the ...
... ,Sosei Group Corporation ("Sosei"; TSE Mothers Index: ... announce results of two Phase II studies,evaluating ... presented at the,annual congress of the European ... data show that NVA237 (glycopyrronium bromide), a ...
Cached Medicine Technology:Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5
(Date:5/6/2015)... MA (PRWEB) May 06, 2015 ... for healthcare professionals and students, announced today that in ... 94% confirmed that use of the clinical decision support ... by the end of 2014, UpToDate users in more ... clinical topics per month, on average. In Germany alone, ...
(Date:5/6/2015)... Anitoa Systems, (“Anitoa”), a Palo Alto startup ... China, has successfully demonstrated a handheld real time quantitative-polymerase-chain-reaction ... Anitoa’s handheld qPCR is shown to be capable of ... hepatitis B, C, and E. Coli. This qPCR system ... and over 9 orders of magnitude dynamic range. ...
(Date:5/6/2015)... In March, Dr. Rami K. Batniji ... Masterclass. As Europe’s most exclusive rhinoplasty conference, the attendees ... Dr. Batniji was hand chosen to speak by the President ... Dr. Pietro Palma. , The Milano Masterclass is ... hosts a diverse, multi-national faculty; each considered a rhinoplasty expert ...
(Date:5/6/2015)... Locally owned, Greek olive oil producer and ... week as having one the best Extra Virgin Olive Oils ... Peloponnese region of Greece and known as Laconiko , ... of Medium Olive Oil, which is defined by the competition ... over 700 producer applicants from 25 different countries applying, Laconiko ...
(Date:5/6/2015)... The Alliance for Regenerative Medicine ... and advanced therapies community, today announced the release ... in-depth look at sector trends and metrics from ... report is available online here and ... available here . , Using information provided ...
Breaking Medicine News(10 mins):Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3Health News:California Surgeon Speaks at International Rhinoplasty Conference 2Health News:Greek Extra Virgin Olive Oil, Laconiko Wins Gold at the NYIOOC and Is Featured in Olive Oil Times as One of Greece's Best EVOO's for 2015 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 3
... labels to help cut heart disease, according to researchers from ... their arguments in this week's British Medical Journal, say that ... number one killer, estimated to be responsible for almost 50 ... cardiovascular disease is reported to cost the EU economy an ...
... because a staff nurse has refused to send an ambulance to ... had an agonizing pain in her lower abdomen. Hence she called ... could not have an ambulance and had to wait for another ... the GP arrived he just gave her some painkillers. ...
... 35-year-old woman in Madhya Pradesh survived carrying a dead foetus ... Friday at the government hospital at Khargone, 348 km from ... removed from her womb. ,Renubai conceived two years ... the seventh month of her pregnancy, her family members thought ...
... it has received the tentative new drug approval ... anti-HIV treatment. // ,The fixed drug ... Abacavir 300mg Tablets, the company informed the Bombay ... is cost-effective and reduces the threat of resistance ...
... of a bird flu vaccine against the deadly H5N1 variety ... unvaccinated monkeys, by researchers at two universities.// ,According ... University, the results are expected to be known within about ... shed light on numerous aspects of the strain's infection mechanism ...
... Act, celebrating its third anniversary, has reduced secondhand smoke ... a study conducted by RTI International. ,According to ... of Health’s Tobacco Control Program, exposure to secondhand smoke ... in the year following the implementation of the law. ...
Cached Medicine News:Health News:Scientists Push for Labeling of all Fats to Avoid Heart Disease 2Health News:New York’s Secondhand Smoke Exposure Continues to Declin 2
... combining the corrosion resistance of stainless ... of copper, SANYO offers an electro-polished ... and maintenance-free. The sterile environment promotes ... results and the safety of laboratory ...
ArcticTemp Upright Freezer -20C. Quick, even freezing. Heavy duty compressor. Deep door racks. Front gated bottom shelf. Interior light. Locks One year warranty on unit and 5 year warranty on compres...
Undercounter Freezer -25C. White. Front opening freezer. 4 cubic ft capacity. Reversible door. Three slide-out drawers. Extra thick CFC insulation. Front lock. Front indicator lights. Attractive tabl...
... highly accurate portable, waterproof system for pH, mV ... pH results can be obtained when used with ... • This GLP/GMP compliant system includes an RS-232 ... computer. Up to 100 data sets can be ...
Medicine Products: